Adherence to lipid lowering drugs is associated with ldl-cholesterol goal achievement.

被引：0

作者：

Pladevall, M. ^{[1
]}

Williams, K. L. ^{[1
]}

Lafata, J. Elston ^{[1
]}

Tunceli, K. ^{[1
]}

Wang, M. ^{[1
]}

Campbell, I. ^{[1
]}

Divine, G. ^{[1
]}

Yang, J. ^{[1
]}

机构：

[1] Henry Ford Hlth Syst, Detroit, MI USA

来源：

AMERICAN JOURNAL OF EPIDEMIOLOGY | 2007年 / 165卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：S11 / S11

页数：1

共 50 条

[31] PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering [J].

Cariou, Bertrand ;

Ding, Zufeng ;

Mehta, Jawahar L. .

ATHEROSCLEROSIS, 2016, 253 :275-277

[32] The in vivo oxidized LDL to LDL-cholesterol ratio is correlated with lipid content of LDL [J].

Wang, JJ ;

Zhuang, YY ;

Liu, XZ ;

Chen, DI .

ATHEROSCLEROSIS, 2000, 149 (01) :217-218

[33] LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia [J].

Tasci, Ilker ;

Erdem, Gokhan ;

Ozgur, Gokhan ;

Tapan, Serkan ;

Dogru, Teoman ;

Genc, Halil ;

Acikel, Cengizhan ;

Ozgurtas, Taner ;

Sonmez, Alper .

ATHEROSCLEROSIS, 2009, 204 (01) :222-228

[34] Cholesterol goal attainment among patients treated with lipid lowering drugs in Hungary [J].

Márk, L ;

Zámoly, K ;

Alemao, E ;

Nagy, L ;

Monori, M ;

Yin, D .

VALUE IN HEALTH, 2004, 7 (06) :707-707

[35] Pleiotropic Effects of StatinsEvidence for Benefits Beyond LDL-Cholesterol Lowering [J].

Mario Marzilli .

American Journal of Cardiovascular Drugs, 2010, 10 :3-9

[36] LDL-Cholesterol Lowering Increased Mortality in Mice with Inherited Cardiomyopathy [J].

Godoy, Joseph C. ;

Schwarz, Anna ;

Schilling, Jan M. ;

Asfaw, Elizabeth K. ;

Alvarez, Erika A. ;

Dalton, Nancy D. ;

Niesman, Ingrid R. ;

Patel, Hemal H. ;

Zemljic-Harpf, Alice E. .

CIRCULATION, 2012, 126 (21)

[37] PREDICTORS OF LDL-CHOLESTEROL (LDL-C) OBJECTIVES ACHIEVEMENT IN FAMILIAL HYPERLIPIDEMIA [J].

Alonso, R. ;

Diaz, J. L. ;

Saenz, P. ;

Ruiz, A. ;

Mata, P. .

ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)

[38] LDL-cholesterol levels in patients with coronary heart disease receiving lipid-lowering therapy: Relation to pretreatment LDL-cholesterol and CHD risk status (reality study, Germany) [J].

Krobot, KJ ;

Yin, D ;

Alemao, E ;

Steinhagen-Thiessen, E .

ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) :129-129

[39] Plasma LDL-cholesterol lowering by LDL apheresis induces acute changes in platelet properties [J].

Korporaal, S. J. A. ;

De Angelis, V ;

Sjouke, B. ;

Van der Stoep, M. ;

Bochem, A. E. ;

Hovingh, K. ;

De Groot, P. G. ;

Van Eck, M. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 :773-773

[40] Low LDL-cholesterol goal attainment 4 months after ACS due to lack of adjustment in lipid lowering treatment: Results from DYSIS II [J].

Gitt, A. K. ;

Lautsch, D. ;

Horack, M. ;

Brudi, P. H. ;

Poh, K. K. ;

De Ferrari, G. ;

Ferrieres, J. .

EUROPEAN HEART JOURNAL, 2017, 38 :30-30

← 1 2 3 4 5 →